医学
雌激素
临床试验
激素替代
绝经后妇女
激素替代疗法(女性对男性)
疾病
随机对照试验
新颖性
激素疗法
内科学
重症监护医学
雌激素替代疗法
生物信息学
物理疗法
乳腺癌
癌症
睾酮(贴片)
哲学
生物
神学
作者
Mehrtash Hashemzadeh,Ryan Romo,Joseph M. Arreguin,Mohammed Reza Movahed
出处
期刊:Future Cardiology
[Future Medicine]
日期:2021-03-01
卷期号:17 (2): 347-353
被引量:9
标识
DOI:10.2217/fca-2020-0054
摘要
Postmenopausal women have an increased risk of cardiovascular disease, which is believed to correlate with lower estrogen level. There are conflicting data regarding hormone replacement therapy (HRT) based on the timing of this therapy. After large randomized trials showed no cardiovascular benefit of hormone replacement, estrogen replacement therapy was dramatically reduced even though starting hormone replacement in early postmenopausal period had shown significant benefit. There are hardly any reviews discussing in detail the effect of HRT on cardiovascular system while briefly discussing other effects of this therapy in postmenopausal women. The novelty of this review is the comprehensive discussion of this effect that can help researchers and clinicians to design future research or trials. In this manuscript, the effect of HRT on cardiovascular system in clinical trials and basic science will be reported and potentially erroneous conclusions drawn by various studies will be discussed. Furthermore, various noncardiovascular effect of HRT will be analyzed.
科研通智能强力驱动
Strongly Powered by AbleSci AI